Citigroup’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-73
| Closed | -$292 | – | 4815 |
|
|
2024
Q4 | $292 | Sell |
73
-565
| -89% | -$2.26K | ﹤0.01% | 4780 |
|
|
2024
Q3 | $7.98K | Sell |
638
-82
| -11% | -$1.03K | ﹤0.01% | 4513 |
|
|
2024
Q2 | $10.5K | Sell |
720
-276
| -28% | -$4.03K | ﹤0.01% | 4385 |
|
|
2024
Q1 | $22.3K | Buy |
996
+288
| +41% | +$6.46K | ﹤0.01% | 4248 |
|
|
2023
Q4 | $13.4K | Buy |
708
+706
| +35,300% | +$13.3K | ﹤0.01% | 4360 |
|
|
2023
Q3 | $42 | Sell |
2
-1,462
| -100% | -$30.7K | ﹤0.01% | 4767 |
|
|
2023
Q2 | $43.9K | Sell |
1,464
-1,313
| -47% | -$39.4K | ﹤0.01% | 4038 |
|
|
2023
Q1 | $81.2K | Buy |
+2,777
| New | +$81.2K | ﹤0.01% | 3474 |
|
|
2022
Q3 | – | Sell |
-44
| Closed | -$1K | – | 5028 |
|
|
2022
Q2 | $1K | Sell |
44
-389
| -90% | -$8.84K | ﹤0.01% | 5188 |
|
|
2022
Q1 | $19K | Sell |
433
-720
| -62% | -$31.6K | ﹤0.01% | 4423 |
|
|
2021
Q4 | $44K | Buy |
1,153
+619
| +116% | +$23.6K | ﹤0.01% | 4363 |
|
|
2021
Q3 | $27K | Buy |
534
+318
| +147% | +$16.1K | ﹤0.01% | 4332 |
|
|
2021
Q2 | $19K | Buy |
+216
| New | +$19K | ﹤0.01% | 4644 |
|